用微针针针针治疗干眼病:一种随机化,假控,临床试验的研究方案
Monica Sun1, Guancheng Li2, Shifen Xu2
1International Education College, Shanghai University of Traditional Chinese Medicine, Shanghai 200120, China.
Complementary therapies in medicine
|October 15, 2025
概括
这项研究研究了一种用于治疗干眼疾病 (DED) 的新型微针针装置,将其在四周内对假治疗和人工眼的疗效进行比较. 结果将确定微针是否为DED症状提供了优越的长期解决方案.
科学领域:
- 眼科和传统中医整合 眼科和传统中医整合
- 在眼睛表面疾病的临床试验研究.
背景情况:
- 干眼病 (DED) 是一种常见的疾病,除了人工眼之外,长期治疗选择有限.
- 微针针针是一种新的非穿透性皮肤疗法,需要对DED管理进行临床验证.
研究的目的:
- 评估微针针治疗干眼疾病的临床有效性和疗效.
- 为了比较微针针与DED患者的假治疗和标准人工眼.
主要方法:
- 一个单中心,随机化,假控制试验,涉及129名DED患者.
- 参与者被随机分配到微针,假药或人工眼组进行四周的治疗.
- 主要结果通过目标症状评分表 (OSSS) 测量;次要结果包括CDEQ,OSDI,NIBUT,SIT,TMH和CFS.
主要成果:
- 该研究旨在收集关于症状改善和眼表面参数在10周内数据.
- 将分析初级和二级结果措施,以评估治疗效果.
- 在第二周,将对NIBUT,SIT,TMH和CFS进行临时测量.
结论:
- 该试验旨在提供强有力的临床证据,证明微针针治疗干眼疾病的治疗潜力.
- 研究结果将为这种新针模式在DED管理中的使用提供信息,并可能提供一种长期治疗替代方案.
相关概念视频
02:07Blind Procedures
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.